Clinical Trials Results - National Cancer Institute

Skip to content

NCI Home

Cancer Topics

Clinical Trials

Cancer Statistics

Research & Funding

News

About NCI


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 29 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase II-III Chemotherapy with Ftorafur vs 5-FU/MeCCNU/TZT vs 5-FU/MeCCNU/ICRF-159 vs 5-FU/MeCCNU/VCR for Advanced Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				no age specified								MAYO-764802

Last Modified: 2/9/2008


2.		Phase III Randomized Study of Oral Uracil/Tegafur (UFT) with Leucovorin vs Fluorouracil with Leucovorin Following Resection for Stage II/III Adenocarcinoma of the Colon

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified				NCI				NSABP-C-06 NSABP-C-06, NCT00378716


3.		Phase III Oral Tegafur vs Intravenous 5-Fluorouracil for Advanced Carcinoma of the Colon and Rectum

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								UCCRC-2993 NCI-V83-0142

Last Modified: 7/1/1995


4.		Phase I/II Study of Oral UFT (Uracil/Tegafur) with CF for Advanced Solid Tumors (Summary Last Modified 07/95)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				18 and over								MSKCC-92037A1 NCI-V92-0097

Last Modified: 3/1/2000 First Published: 3/1/1998


5.		Phase II Study of Oral Uracil and Tegafur Plus Leucovorin Calcium in Advanced Local-Regional or Metastatic Squamous Cell Carcinoma of the Head and Neck (Summary Last Modified 03/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				DFCI-96082 BMS-CA146-020, MGH-M6-37, NCI-G98-1384


6.		Phase II Chemotherapy with Ftorafur for Metastatic Adenocarcinoma of the Colon and Rectum

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				no age specified				NCI				SWOG-7619


7.		Phase II Chemotherapy with MeCCNU/TGDR vs MITO/TGDR vs MITO/5-FU for Refractory Disseminated Colorectal Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				no age specified				NCI				SWOG-7634


8.		Phase II Comparison of Ftorafur/MITO-C vs Ftorafur/MeCCNU for Adenocarcinoma of the Colon and Rectum

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								WSU-C-19676


9.		Phase II Chemotherapy with Ftorafur for Adenocarcinoma of the Colon and Rectum After Prior Treatment with 5-FU or FUDR

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								WSU-C-20276


10.		Phase II Evaluation of Ftorafur for Advanced Squamous Cell and Adenocarcinomas of the Head and Neck

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								WSU-C-22077

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute